CSIMarket
 


Avita Medical Inc   (RCEL)
Other Ticker:  
 
 

RCEL's Revenue Growth by Quarter and Year

Avita Medical Inc 's Revenue results by quarter and year




RCEL Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 9.46 7.02 5.06
III Quarter September 13.65 9.09 10.30 0.00
II Quarter June 11.75 8.34 8.77 0.00
I Quarter March 10.55 7.54 5.10 0.00
FY   35.95 34.43 31.19 5.06



RCEL Revenue third quarter 2023 Y/Y Growth Comment
Avita Medical Inc achieved in the third quarter 2023, above Company average Revenue rise of 50.11% year on year, to $ 13.65 millions.

Looking into third quarter 2023 results within Medical Equipment & Supplies industry 91 other companies have achieved higher Revenue growth. While Avita Medical Inc ' s Revenue jump of 50.11% ranks overall at the positon no. 1836 in the third quarter 2023.




RCEL Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - 34.76 % 38.74 % -
III Quarter September 50.11 % -11.75 % - -
II Quarter June 40.89 % -4.9 % - -
I Quarter March 39.92 % 47.84 % - -
FY   - 10.39 % 516.4 % -

Financial Statements
Avita Medical Inc 's third quarter 2023 Revenue $ 13.65 millions RCEL's Income Statement
Avita Medical Inc 's third quarter 2022 Revenue $ 9.09 millions Quarterly RCEL's Income Statement
New: More RCEL's historic Revenue Growth >>


RCEL Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 4.07 % -31.84 % -
III Quarter September 16.13 % 8.99 % 17.45 % -
II Quarter June 11.37 % 10.61 % 71.96 % -
I Quarter March 11.52 % 7.41 % 0.79 % -
FY (Year on Year)   - 10.39 % 516.4 % -




Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #92
Healthcare Sector #287
Overall #1836

Revenue Y/Y Growth Statistics
High Average Low
41.95 % 19.22 % 9.42 %
(Sep 30 2023)   (Sep 30 2022)
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #92
Healthcare Sector #287
Overall #1836
Revenue Y/Y Growth Statistics
High Average Low
41.95 % 19.22 % 9.42 %
(Sep 30 2023)   (Sep 30 2022)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Avita Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
71.76 % 12.1 % -31.87 %
(Mar 31 2021)  


RCEL's III. Quarter Q/Q Revenue Comment
Avita Medical Inc achieved in the III. Quarter 2023 above company average sequential Revenue jump of 16.13%, to $ 13.65 millions, from $11.75 millions in the second quarter.
RCEL is going from strength to strength, not only claiming better then average growth, but also improving rate.

Within Medical Equipment & Supplies industry 29 other companies have achieved higher Revenue quarter on quarter growth. While Avita Medical Inc 's Revenue growth quarter on quarter, overall rank is 563.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #30
Healthcare Sector #168
Overall #563
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #30
Healthcare Sector #168
Overall #563
Revenue Q/Q Growth Statistics
High Average Low
71.76 % 12.1 % -31.87 %
(Mar 31 2021)  


RCEL's III. Quarter Q/Q Revenue Comment
Avita Medical Inc achieved in the III. Quarter 2023 above company average sequential Revenue jump of 16.13%, to $ 13.65 millions, from $11.75 millions in the second quarter.
RCEL is impressively improving, not just reporting above normal growth, but also accelerating rate.

Within Medical Equipment & Supplies industry 29 other companies have achieved higher Revenue quarter on quarter growth. While Avita Medical Inc 's Revenue growth quarter on quarter, overall rank is 563.


Avita Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 45.40 $ 40.85 $ 37.43 $ 34.42 $ 31.99
Y / Y Revenue Growth (TTM) 41.95 % 23.05 % 11.31 % 10.35 % 9.42 %
Year on Year Revenue Growth Overall Ranking # 1011 # 1287 # 1699 # 1321 # 1410
Seqeuential Revenue Change (TTM) 11.15 % 9.13 % 8.75 % 7.61 % -3.65 %
Seq. Revenue Growth (TTM) Overall Ranking # 1836 # 2524 # 1816 # 1514 # 1645




Cumulative Revenue growth Comment
With 41.95% annual Revenue growth, Avita Medical Inc would report a record annual Revenue growth if the fiscal year would end on Sep 30 2023.

In the Healthcare sector 198 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1011, from total ranking in previous quarter at 1287.

Revenue TTM Q/Q Growth Statistics
High Average Low
41.95 %
19.22 %
9.42 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 92
Healthcare Sector # 199
Overall # 1011

Revenue TTM Y/Y Growth Statistics
High Average Low
41.95 %
19.22 %
9.42 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 92
Sector # 287
S&P 500 # 1836
Cumulative Revenue growth Comment
With 41.95% annual Revenue growth, Avita Medical Inc would report a record annual Revenue growth if the fiscal year would end on Sep 30 2023.

In the Healthcare sector 198 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1011, from total ranking in previous quarter at 1287.

Revenue TTM Q/Q Growth Statistics
High Average Low
41.95 %
19.22 %
9.42 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 92
Healthcare Sector # 199
Overall # 1011

Revenue TTM Y/Y Growth Statistics
High Average Low
41.95 %
19.22 %
9.42 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 92
Sector # 287
S&P 500 # 1836




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RCEL's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for RCEL's Competitors
Revenue Growth for Avita Medical Inc 's Suppliers
Revenue Growth for RCEL's Customers

You may also want to know
RCEL's Annual Growth Rates RCEL's Profitability Ratios RCEL's Asset Turnover Ratio RCEL's Dividend Growth
RCEL's Roe RCEL's Valuation Ratios RCEL's Financial Strength Ratios RCEL's Dividend Payout Ratio
RCEL's Roa RCEL's Inventory Turnover Ratio RCEL's Growth Rates RCEL's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Xoma Corporation84.04%$ 84.035 millions
Catalyst Pharmaceuticals Inc 79.39%$ 79.386 millions
Esperion Therapeutics inc 78.97%$ 78.973 millions
Docgo Inc 78.83%$ 78.828 millions
Precision Biosciences Inc78.19%$ 78.188 millions
Marpai Inc 76.77%$ 76.771 millions
Bicycle Therapeutics Plc76.05%$ 76.053 millions
Intra cellular Therapies Inc 75.56%$ 75.557 millions
Agilon Health Inc 74.95%$ 74.951 millions
Rxsight Inc 72.26%$ 72.263 millions
Elite Pharmaceuticals Inc 71.86%$ 71.860 millions
Procept Biorobotics Corporation71.38%$ 71.379 millions
Pacific Biosciences Of California Inc 69.92%$ 69.917 millions
Biocardia Inc68.40%$ 68.396 millions
Xtant Medical Holdings Inc 68.26%$ 68.262 millions
Cvrx inc67.98%$ 67.978 millions
Merus N v 67.65%$ 67.649 millions
Alimera Sciences Inc 66.25%$ 66.245 millions
Coherus Biosciences inc 64.16%$ 64.160 millions
C4 Therapeutics Inc 63.93%$ 63.932 millions
Y mabs Therapeutics inc 63.15%$ 63.149 millions
Nanostring Technologies Inc 62.79%$ 62.787 millions
Xeris Biopharma Holdings Inc 62.56%$ 62.557 millions
Adma Biologics Inc 62.21%$ 62.211 millions
Acadia Pharmaceuticals Inc 61.96%$ 61.956 millions
Orthofix Medical Inc 61.20%$ 61.201 millions
Molecular Templates inc 60.28%$ 60.283 millions
Sintx Technologies Inc 59.15%$ 59.155 millions
Ani Pharmaceuticals Inc57.27%$ 57.274 millions
Predictive Oncology Inc 56.87%$ 56.870 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com